Skip to main content

Table 3 Patients’ characteristics, surgical and pathological information of salvage group

From: Long-term outcomes of transanal endoscopic microsurgery for the treatment of rectal neuroendocrine tumors

 

Tumor detected (n = 25)

No tumor detected (n = 8)

P-value

Age, median (range), years

46 (32–74)

38.5 (33–66)

0.159

Male, N (%)

14 (56.0)

8 (100.0)

0.062

BMI, mean (SD)

25.5 (3.0)

25.1 (2.6)

0.703

Symptomatic, N (%)

10 (40.0)

3 (37.5)

1.000

CA242, median (range), U/ml

6.7 (0.3–31.5)

4.3 (0.7–22.1)

0.141

CEA, median (range), ng/ml

1.6 (0.2–4.4)

2.1 (1.3–3.9)

0.274

CA19-9, median (range), U/ml

10.5 (0.6–34.0)

7.5 (0.6–22.5)

0.179

Primary tumor size, cm

 < 1 cm, N (%)

23 (92.0)

8 (100.0)

1.000

 1–2 cm, N (%)

2 (8.0)

0 (0.0)

 

Distance from anal verge, cm

 ≤ 6 cm, N (%)

16 (64.0)

6 (75.0)

0.886

 > 6 cm, N (%)

9 (36.0)

2 (25.0)

 

Location, N (%)

 Anterior

11 (44.0)

2 (25.0)

0.516

 Posterior

5 (20.0)

3 (37.5)

 

 Lateral

9 (36.0)

3 (37.5)

 

Operative time, median (range), minutes

60 (25–130)

67.5 (50–120)

0.526

Blood loss, ml

 ≤ 5 ml, N (%)

24 (96.0)

7 (87.5)

0.979

 > 5 ml, N (%)

1 (4.0)

1 (12.5)

 

Postoperative hospital stay, median (range), days

2 (1–3)

2 (1–3)

0.703

Grade, N (%)

 G1

19 (76.0)

7 (87.5)

0.845

 G2

6 (24.0)

1 (12.5)

 

Invasion depth, N (%)

 Mucosa

11 (44.0)

1 (12.5)

0.234

 Submucosa

14 (56.0)

7 (87.5)

 

Negative resection margin, N (%)

25 (100.0)

8 (100.0)